» Articles » PMID: 32160149

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

Abstract

The etiologic agent of an outbreak of pneumonia in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 in January 2020. A patient in the United States was given a diagnosis of infection with this virus by the state of Washington and the US Centers for Disease Control and Prevention on January 20, 2020. We isolated virus from nasopharyngeal and oropharyngeal specimens from this patient and characterized the viral sequence, replication properties, and cell culture tropism. We found that the virus replicates to high titer in Vero-CCL81 cells and Vero E6 cells in the absence of trypsin. We also deposited the virus into 2 virus repositories, making it broadly available to the public health and research communities. We hope that open access to this reagent will expedite development of medical countermeasures.

Citing Articles

Spatial analysis of COVID-19 incidence and mortality rates in northwest iran for future epidemic preparedness.

Soleimani M, Jalilvand A Sci Rep. 2025; 15(1):7450.

PMID: 40032988 PMC: 11876366. DOI: 10.1038/s41598-025-91246-y.


SARS-CoV-2 EndoU-ribonuclease regulates RNA recombination and impacts viral fitness.

Zhou Y, Ahearn Y, Lokugamage K, Alvarado R, Estes L, Meyers W bioRxiv. 2024; .

PMID: 39605585 PMC: 11601229. DOI: 10.1101/2024.11.11.622995.


SARS-CoV-2 Rapidly Infects Peripheral Sensory and Autonomic Neurons, Contributing to Central Nervous System Neuroinvasion before Viremia.

Joyce J, Moore G, Goswami P, Harrell T, Taylor T, Hawks S Int J Mol Sci. 2024; 25(15).

PMID: 39125815 PMC: 11311394. DOI: 10.3390/ijms25158245.


Identification of South African Plant-Based Bioactive Compounds as Potential Inhibitors against the SARS-CoV-2 Receptor.

Mkolo N, Naidoo C, Kadye R, Obi C, Iweriebor B, Olaokun O Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065672 PMC: 11279959. DOI: 10.3390/ph17070821.


Chinese Medicine for Treatment of COVID-19: A Review of Potential Pharmacological Components and Mechanisms.

Xu Q, Yu D, Fan X, Cui H, Dai Q, Zhong X Chin J Integr Med. 2024; 31(1):83-95.

PMID: 38958885 DOI: 10.1007/s11655-024-3909-z.


References
1.
Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

2.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

3.
Swayne D, Suarez D, Spackman E, Tumpey T, Beck J, Erdman D . Domestic poultry and SARS coronavirus, southern China. Emerg Infect Dis. 2004; 10(5):914-6. PMC: 3323233. DOI: 10.3201/eid1005.030827. View

4.
Holshue M, DeBolt C, Lindquist S, Lofy K, Wiesman J, Bruce H . First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020; 382(10):929-936. PMC: 7092802. DOI: 10.1056/NEJMoa2001191. View

5.
Wan Y, Shang J, Graham R, Baric R, Li F . Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020; 94(7). PMC: 7081895. DOI: 10.1128/JVI.00127-20. View